Korean drug price reform will hurt pharmaceutical sector

Published: 2010-02-19 06:59:00

Updated: 2010-02-19 06:59:00

Korea's pharmaceutical sector could lose up to 3 trillion won if the government’s drug price reform plan takes into effect this October, according to the Korea Pharmaceutical Manufacturers Association.

The estimated losses are based on an assumption that if the controversial incentive system f...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK